Novavax Kickstarts Phase 2 Trial For COVID-19-Flu Combo, Stand-Alone Flu Vaccine Candidates – Novavax (NASDAQ:NVAX)
[ad_1] Novavax Inc NVAX has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates. The dose-confirming trial will evaluate the safety and effectiveness (immunogenicity)…
NaaS Technology Appoints Alex Wu As Finance Chief – Naas Technology (NASDAQ:NAAS)
[ad_1] NaaS Technology Inc NAAS has appointed Alex Wu as its Chief Financial Officer, effective January 15, 2023. Wu has also been appointed the President of the company and will…
iM’s Business Cycle Index Signals A Looming Recession
[ad_1] gguy44 In 2013, we developed our Business Cycle Index from the following basic economic data: 10-year treasury yield (daily) 3-month treasury bill yield (daily) S&P500 (daily) Continues Claims Seasonally…
New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows – Pfizer (NYSE:PFE)
[ad_1] by Vandana Singh, Benzinga Editor December 30, 2022 7:39 AM | 1 min read A study in China shows that a remdesivir analog, dubbed VV116, is as effective…
Spain brings in controls on travellers from China as EU split widens
[ad_1] The split in Europe’s response to China’s coronavirus surge widened on Friday as Spain followed Italy by announcing new controls on travellers arriving from the Asian country even as…